만성 골수성 백혈병(CML) : 역학 예측(-2030년)
Chronic Myeloid Leukemia (CML) - Epidemiology Forecast to 2030
만성 골수성 백혈병(CML) 주요 8개 시장(8MM : 미국, 프랑스, 독일, 이탈리아, 스페인, 영국, 일본, 캐나다)의 진단된 인시던트 케이스는 2020년에 1만 5,515건이 되고, 2030년에는 1만 7,562건이 될 것으로 예측됩니다. 또한 예측기간 중 AGR은 1.32%입니다.
8MM의 만성 골수성 백혈병(CML) 시장을 조사했으며, CML의 위험인자, 병존질환, COVID-19의 영향, 세계 및 과거의 역학적 동향에 대해 설명하고 있습니다.
Chronic myeloid leukemia (CML) (ICD-10 = C92.1) is a rare cancer of the white blood cells characterized by increased and unregulated growth of myeloid cells originating in the bone marrow that invade the blood and potentially other organs, depending on the phase of the cancer (American Cancer Society, 2018; Mayo Clinic, 2021). In CML, a genetic change takes place in an early (immature) version of myeloid cells, the cells that make red blood cells, platelets, and most types of white blood cells (except lymphocytes). Based on clinical characteristics and laboratory findings, CML is divided into three phases: chronic, accelerated, and blast crisis; most people with CML are diagnosed at the chronic phase (American Cancer Society, 2018).
This report provides an overview of the risk factors, comorbidities, and the global and historical epidemiological trends for CML in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Canada). The report includes a 10-year epidemiology forecast for the diagnosed incident cases of CML. The diagnosed incident cases are segmented by age (all ages), sex, staging (chronic phase, accelerated phase, and blast phase), risk status (low-risk, intermediate-risk, and high-risk), and T315I mutation. The report also provides a 10-year epidemiological forecast of the 20-year diagnosed prevalent cases of CML. The following data describes epidemiology of CML. In the 8MM, GlobalData epidemiologists forecast an increase in the diagnosed incident cases of CML from 15,515 diagnosed incident cases of CML in 2020 to 17,562 diagnosed incident cases of CML in 2030, with an AGR of 1.32% during the forecast period. The 20-year diagnosed prevalent cases of CML in the 8MM are expected to increase from 142,404 cases in 2020 to 170,488 cases in 2030, with an AGR of 1.97% during the forecast period. Men accounted for more diagnosed incident cases of CML than women in the 8MM and it predominantly affects older adults. These findings are in line with the GlobalData estimates and these trends are reflected in GlobalData's forecast for the diagnosed incident cases for the 8MM.
The Chronic Myeloid Leukemia (CML) Epidemiology series will allow you to -